Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF GASTROENTEROLOGY
Volume 110, Issue 6, Pages 857-864
Publisher
Springer Nature
Online
2015-04-28
DOI
10.1038/ajg.2015.118
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Levels of Alkaline Phosphatase and Bilirubin Are Surrogate End Points of Outcomes of Patients With Primary Biliary Cirrhosis: An International Follow-up Study
- (2014) Willem J. Lammers et al. GASTROENTEROLOGY
- Elevated serum levels ofWisteria floribundaagglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients
- (2014) Kazumi Yamasaki et al. HEPATOLOGY
- A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis
- (2014) Takeo Toshima et al. JOURNAL OF GASTROENTEROLOGY
- Optimising risk stratification in primary biliary cirrhosis: AST/platelet ratio index predicts outcome independent of ursodeoxycholic acid response
- (2014) Palak J. Trivedi et al. JOURNAL OF HEPATOLOGY
- Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
- (2014) Takeji Umemura et al. PLoS One
- Early biochemical response to ursodeoxycholic acid and long-term prognosis of primary biliary cirrhosis: Results of a 14-year cohort study
- (2013) Li-Na Zhang et al. HEPATOLOGY
- A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis
- (2013) Atsushi Kuno et al. Scientific Reports
- Noninvasive elastography-based assessment of liver fibrosis progression and prognosis in primary biliary cirrhosis
- (2012) Christophe Corpechot et al. HEPATOLOGY
- Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
- (2011) Takeji Umemura et al. HEPATOLOGY
- Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
- (2011) Christophe Corpechot et al. JOURNAL OF HEPATOLOGY
- Primary biliary cirrhosis
- (2011) Carlo Selmi et al. LANCET
- Baseline Ductopenia and Treatment Response Predict Long-Term Histological Progression in Primary Biliary Cirrhosis
- (2010) Teru Kumagi et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Serological markers for monitoring disease progression in noncirrhotic primary biliary cirrhosis on ursodeoxycholic acid therapy
- (2010) Martti Färkkilä et al. LIVER INTERNATIONAL
- Improved Prognosis of Patients With Primary Biliary Cirrhosis That Have a Biochemical Response to Ursodeoxycholic Acid
- (2009) Edith M.M. Kuiper et al. GASTROENTEROLOGY
- Primary biliary cirrhosis
- (2009) Keith D. Lindor et al. HEPATOLOGY
- Biochemical markers for non-invasive assessment of disease stage in patients with primary biliary cirrhosis
- (2009) Tamara Alempijevic et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay
- (2008) Marlyn J. Mayo et al. HEPATOLOGY
- Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis
- (2008) Christophe Corpechot et al. HEPATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More